Trestle Biotherapeutics

Trestle Biotherapeutics is dedicated to creating an innovative implantable therapeutic tissue designed to address end-stage renal disease. This bioengineered kidney tissue is surgically implanted to augment the patient's kidney function, with the primary goal of freeing individuals from the burden of dialysis and enhancing their overall health. The potential impact is substantial, offering patients and their families a life beyond dialysis while also significantly delaying the need for a full kidney transplant. This groundbreaking approach aims to revolutionize the treatment of kidney failure and improve the lives of countless patients.